$PFHO
PACIFIC HEALTH CARE ORGANIZATION INC

2024 Q4 Form 10-Q Financial Statement

#000118518524001057 Filed on November 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $1.528M
YoY Change 11.02%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.384K
YoY Change -6.18%
% of Gross Profit
Operating Expenses $1.376M
YoY Change 11.97%
Operating Profit $151.6K
YoY Change 3.11%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $8.783K
YoY Change 94.14%
Pretax Income $265.2K
YoY Change 6.5%
Income Tax $90.35K
% Of Pretax Income 34.07%
Net Earnings $174.9K
YoY Change -2.38%
Net Earnings / Revenue 11.45%
Basic Earnings Per Share $0.01
Diluted Earnings Per Share $0.01
COMMON SHARES
Basic Shares Outstanding 12.80M shares 12.80M shares
Diluted Shares Outstanding 12.82M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $2.546M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $1.093M
Other Receivables
Total Short-Term Assets $12.07M
YoY Change 7.48%
LONG-TERM ASSETS
Property, Plant & Equipment $57.93K
YoY Change -21.59%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.110K
YoY Change 0.0%
Total Long-Term Assets $65.04K
YoY Change -19.69%
TOTAL ASSETS
Total Short-Term Assets $12.07M
Total Long-Term Assets $65.04K
Total Assets $12.14M
YoY Change 7.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $175.0K
YoY Change 43.49%
Accrued Expenses $440.4K
YoY Change 39.96%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $747.5K
YoY Change -3.73%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $747.5K
Total Long-Term Liabilities
Total Liabilities $747.5K
YoY Change -5.64%
SHAREHOLDERS EQUITY
Retained Earnings $10.96M
YoY Change 8.61%
Common Stock $12.80K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.39M
YoY Change
Total Liabilities & Shareholders Equity $12.14M
YoY Change 7.29%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $174.9K
YoY Change -2.38%
Depreciation, Depletion And Amortization $8.384K
YoY Change -6.18%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0285238
dei Entity Registrant Name
EntityRegistrantName
PACIFIC HEALTH CARE ORGANIZATION, INC.
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92612
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-50009
dei Entity Address Address Line1
EntityAddressAddressLine1
19800 MacArthur Boulevard, Suites 306 & 307
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
721-8272
dei Security12b Title
Security12bTitle
None
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12800000 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2545913 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2565992 usd
CY2024Q3 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
8197570 usd
CY2023Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
7877752 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
11862 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
32814 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1093407 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1020580 usd
CY2024Q3 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
1590 usd
CY2023Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
0 usd
CY2024Q3 us-gaap Deferred Income Taxes And Other Assets Current
DeferredIncomeTaxesAndOtherAssetsCurrent
51018 usd
CY2023Q4 us-gaap Deferred Income Taxes And Other Assets Current
DeferredIncomeTaxesAndOtherAssetsCurrent
38871 usd
CY2024Q3 us-gaap Prepaid Taxes
PrepaidTaxes
32539 usd
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
0 usd
CY2024Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
151914 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
179702 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
12073951 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
11682897 usd
CY2024Q3 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
242848 usd
CY2023Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
255783 usd
CY2024Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
13283 usd
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
21620 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
256131 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
277403 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
198202 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
200009 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
57929 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
77394 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
56489 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7110 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7110 usd
CY2024Q3 us-gaap Assets
Assets
12138990 usd
CY2023Q4 us-gaap Assets
Assets
11823890 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
174952 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
159789 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
440424 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
367609 usd
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
296452 usd
CY2024Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
94858 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
109013 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
44519 usd
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
37315 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
30919 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
747549 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1008301 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11970 usd
CY2024Q3 us-gaap Liabilities
Liabilities
747549 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1020271 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
16 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
16 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
12800 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
12800 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
416057 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
416057 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10962568 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10374746 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
11391441 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
10803619 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12138990 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11823890 usd
CY2024Q3 us-gaap Revenues
Revenues
1527725 usd
CY2023Q3 us-gaap Revenues
Revenues
1405863 usd
us-gaap Revenues
Revenues
4524390 usd
us-gaap Revenues
Revenues
4071454 usd
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8384 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8936 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26925 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27652 usd
CY2024Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1082 usd
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1265 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-20952 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2429 usd
CY2024Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
58035 usd
CY2023Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
56418 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
176315 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
173235 usd
CY2024Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
723080 usd
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
646423 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
2069577 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1949923 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
99606 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
89677 usd
us-gaap Professional Fees
ProfessionalFees
302795 usd
us-gaap Professional Fees
ProfessionalFees
263880 usd
CY2024Q3 us-gaap General Insurance Expense
GeneralInsuranceExpense
90118 usd
CY2023Q3 us-gaap General Insurance Expense
GeneralInsuranceExpense
81003 usd
us-gaap General Insurance Expense
GeneralInsuranceExpense
248223 usd
us-gaap General Insurance Expense
GeneralInsuranceExpense
229599 usd
CY2024Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
195852 usd
CY2023Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
202268 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
585338 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
590860 usd
CY2024Q3 us-gaap Other Expenses
OtherExpenses
8783 usd
CY2023Q3 us-gaap Other Expenses
OtherExpenses
4524 usd
us-gaap Other Expenses
OtherExpenses
75285 usd
us-gaap Other Expenses
OtherExpenses
69278 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
193372 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
168344 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
542121 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
390019 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
1376148 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1258858 usd
us-gaap Operating Expenses
OperatingExpenses
4005627 usd
us-gaap Operating Expenses
OperatingExpenses
3696875 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
151577 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
147005 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
518763 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
374579 usd
CY2024Q3 us-gaap Interest Income Other
InterestIncomeOther
113634 usd
CY2023Q3 us-gaap Interest Income Other
InterestIncomeOther
102017 usd
us-gaap Interest Income Other
InterestIncomeOther
319883 usd
us-gaap Interest Income Other
InterestIncomeOther
301991 usd
CY2024Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
113634 usd
CY2023Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
102017 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
319883 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
301991 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
265211 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
249022 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
838646 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
676570 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
90348 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
69901 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
250824 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
189913 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
174863 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
179121 usd
us-gaap Net Income Loss
NetIncomeLoss
587822 usd
us-gaap Net Income Loss
NetIncomeLoss
486657 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11317291 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
131109 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
11448400 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
176427 usd
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1280000 usd
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1600 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
10343227 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
179121 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
10522348 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
10803619 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
197403 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
11001022 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
215556 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
11216578 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
174863 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
11391441 usd
us-gaap Net Income Loss
NetIncomeLoss
587822 usd
us-gaap Net Income Loss
NetIncomeLoss
486657 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26925 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27652 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-20952 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2429 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
143634 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
126422 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
51875 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-99735 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-27788 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
14090 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1590 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-3000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
12147 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
82000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
508 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
15163 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-141097 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
72815 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-17864 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
6396 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3771 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-328991 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
190126 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
177720 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
431389 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
7877752 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
8748435 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
8053936 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
7642981 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7460 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4126 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-183644 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1101328 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
14155 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
1209267 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-14155 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1209267 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-20079 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
323450 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2565992 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2036432 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2545913 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2359882 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
598000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
82000 usd
us-gaap Dividends
Dividends
57858 usd
us-gaap Dividends
Dividends
72333 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Reclassifications</i></b> – Certain reclassifications have been made to prior year amounts to conform to the current year presentations. These changes had no impact on the Company’s total assets or reported net income.</p>
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
11862 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
32814 usd
pfho Number Of Customers
NumberOfCustomers
3 pure
CY2023Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
us-gaap Operating Lease Expense
OperatingLeaseExpense
34941 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
31407 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
us-gaap Dividends Cash
DividendsCash
1281600 usd
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
16000 shares
us-gaap Net Income Loss
NetIncomeLoss
587822 usd
us-gaap Net Income Loss
NetIncomeLoss
486657 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Net Income Loss
NetIncomeLoss
587822 usd
us-gaap Net Income Loss
NetIncomeLoss
486657 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
90348 usd
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.332 pure
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
250824 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.297 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
69901 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
189913 usd
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001138476

Files In Submission

Name View Source Status
0001185185-24-001057-index-headers.html Edgar Link pending
0001185185-24-001057-index.html Edgar Link pending
0001185185-24-001057.txt Edgar Link pending
0001185185-24-001057-xbrl.zip Edgar Link pending
ex_740307.htm Edgar Link pending
ex_740308.htm Edgar Link pending
ex_740309.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pacifichco20240930_10q.htm Edgar Link pending
pfho-20240930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pfho-20240930_def.xml Edgar Link unprocessable
pfho-20240930_lab.xml Edgar Link unprocessable
pfho-20240930_cal.xml Edgar Link unprocessable
pfho-20240930_pre.xml Edgar Link unprocessable
pacifichco20240930_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable